Craniosacral therapy marketing: what you can claim

Craniosacral therapy is offered by massage therapists, osteopathic physicians, chiropractors, physical and occupational therapists, and practitioners trained only in the method itself. Its marketing covers a wide range: “a gentle, quiet session,” “relief for migraines and back pain,” “helps babies with colic, latch and birth trauma,” and “releases restrictions in the craniosacral system.” The first describes an experience. The rest are health claims, and federal law asks whether you have evidence for them before you publish.

This guide covers what the research reviews say, how FTC rules apply to craniosacral ads, why claims about babies need the most care, and how to handle reviews, credentials and packages. We do not name any practitioner, school, brand or company. For related hands-on services, see our guides to massage therapy marketing and reiki marketing claims.

This is general information, not legal or medical advice. Sources cited were checked on November 1, 2026: the PubMed records and PubMed Central full text of a 2024 systematic review and meta-analysis of craniosacral therapy (Healthcare, March 2024) and a 2019 meta-analysis of craniosacral therapy for chronic pain (BMC Musculoskeletal Disorders); the PubMed record of a 2023 meta-analysis of non-drug interventions for infant colic; the National Library of Medicine MeSH record for Musculoskeletal Manipulations; 15 USC 45 and 52 in the Cornell LII text of the U.S. Code; 16 CFR 233.1, 255.2 and 255.5 in the eCFR version as of October 29, 2026; the FTC Health Products Compliance Guidance (December 2022); and FDA’s guidance General Wellness: Policy for Low Risk Devices (issued January 6, 2026). We found no NCCIH health topic page on craniosacral therapy and did not read any state licensing law. Who may perform hands-on therapy, and under what title, depends on your state and license. Check your board’s rules before you advertise.

The short version

The evidence is mixed at best. A 2019 meta-analysis of 10 trials found small to moderate effects on chronic pain. A 2024 review of 15 trials, including newer ones, concluded craniosacral therapy produced no benefit in any condition it assessed. Claims need to reflect that disagreement.
Babies are the highest-risk claim. The 2024 review found craniosacral therapy was not effective for infant colic or preterm infants. “Fixes colic,” “corrects latch” or “releases birth trauma” are not supported.
Describe the session, not the mechanism. The 2024 review says the reliability of palpating the proposed craniosacral rhythm is not supported by sound evidence. “We feel and correct your cranial rhythm” states a mechanism as fact.
Wellness wording is safer. “A quiet, gentle hands-on session” describes an experience. “Treats migraines, anxiety and concussion” is a disease claim that needs competent and reliable scientific evidence.
Reviews count as your claims. A testimonial that says craniosacral therapy cured a condition is a claim you make when you feature it (16 CFR 255.2).

What craniosacral therapy is, in plain words

The National Library of Medicine lists “craniosacral massage” as an entry term under its Musculoskeletal Manipulations heading, the same family as other manual therapies. The 2024 review describes the method’s model: practitioners hold that the bones of the skull and the membranes and fluid around the brain and spinal cord move in a rhythm that can be felt by light touch, and that gentle pressure can correct restrictions in it. The review also notes that the cranial sutures fuse completely between the ages of 13 and 18, and that studies of whether practitioners can reliably feel this rhythm had a high risk of bias and failed to show reliability.

For marketing, that means:

You can describe what happens in your sessions: light touch, where you place your hands, how long it lasts and that the client stays clothed. That is a factual description of your service.
Avoid stating the model as established fact. “Craniosacral therapy is based on the idea that…” is accurate. “We release blockages in your cerebrospinal fluid flow” claims a physical effect you cannot show.
Avoid diagnostic language. “We detect restrictions that cause your headaches” is a diagnostic claim. If you are not licensed to diagnose, it can also cross your scope of practice.

What the reviews say about pain and other conditions

Under the FTC Act, an ad is deceptive if its net impression misleads, and health benefit claims need competent and reliable scientific evidence (15 USC 45 and 52; FTC Health Products Compliance Guidance). The research on craniosacral therapy points in two directions:

A 2019 systematic review and meta-analysis in BMC Musculoskeletal Disorders pooled 10 randomized trials with 681 patients with neck and back pain, migraine, headache, fibromyalgia, epicondylitis and pelvic girdle pain. It found greater reductions in pain intensity and disability than usual care, sham or other manual treatments, with effects up to six months, and called for more trials to confirm them.
A 2024 systematic review and meta-analysis in Healthcare, searched through August 2023, included 15 randomized trials. It found no statistically significant or clinically relevant changes in pain or disability for headache disorders, neck pain, low back pain, pelvic girdle pain or fibromyalgia, and concluded that craniosacral therapy produced no benefits in any condition it assessed. It noted that only one of the higher-quality trials it scored reported a positive result.
On safety, the 2024 review reports that 10 of its 15 trials did not mention adverse events, and the 5 that did reported no serious adverse events. Absence of reported harm in small trials is not proof of safety.

In practice:

“Many clients find sessions relaxing” is a description. “Relieves chronic pain” is a health claim. If you make it, say what the evidence is and how mixed it is, for example “some studies of chronic neck and back pain have reported improvement; others have not.”
Do not list a string of conditions, such as autism, ADHD, concussion, TMJ, depression, vertigo and learning problems, as things you treat. The 2024 review found no benefit for cerebral palsy or visual function deficits, and we found no review supporting the others.
“Clinically proven” and “research shows” claims need research that shows what you say, for the condition you name. A single uncontrolled study does not make a treatment proven.
If you are licensed to treat a condition and use craniosacral techniques as part of a broader plan, advertise the plan you deliver and your license, not craniosacral therapy as the cure.

Babies, colic, latch and birth claims

Infant claims carry the most risk. Parents searching “craniosacral for colic” or “craniosacral after birth” are often tired and worried, and an ad that promises a fix can delay care for a feeding or medical problem.

The 2024 review found craniosacral therapy was not effective for infant colic or preterm infants, and it said two trials in children that reported benefits were seriously flawed and likely false positives.
A 2023 meta-analysis of three trials with 386 infants with colic reported less crying after non-drug treatments that included chiropractic, craniosacral and acupuncture approaches. It pooled different treatments, so it does not show that craniosacral therapy alone works for colic.
Do not say craniosacral therapy fixes latch, tongue-tie or reflux. Feeding problems in babies need assessment by a pediatric clinician or lactation professional. Our guides to tongue-tie and frenectomy marketing and lactation consultant marketing cover those services.
“Birth trauma release” implies an injury your session repairs. If you use the phrase, you need evidence for that effect. Describing a gentle session for parent and baby is safer.
Say clearly that craniosacral sessions do not replace pediatric care, and that a baby with fever, poor feeding, breathing problems or unusual crying should be seen by a doctor. In an emergency, call 911.

Wellness wording vs health claims

Craniosacral therapy is a hands-on service, not a product, so FDA’s device rules do not decide what a practitioner may say. FDA’s general wellness guidance is still a useful model for where the line sits. It describes general wellness claims that make no reference to diseases or conditions, such as relaxation or stress management, and treats claims about diagnosing, treating or curing a disease as a different category. The guidance covers low-risk products, not services, and it does not change what the FTC accepts as evidence.

Wording that describes the experience:

“A quiet, gentle session with light touch. You stay clothed and lie on a padded table.”
“Time to rest and slow down.”
“Sessions last about an hour. Tell us about any health conditions before your first visit.”

Wording that makes health claims and needs evidence:

“Cures migraines” or “ends chronic pain.”
“Heals concussion and brain injury.”
“Resets your nervous system” or “balances cerebrospinal fluid.”
“Treats anxiety, depression and PTSD.”

Reviews, credentials and prices

Testimonials. Featuring a review that says “my migraines disappeared” means you are making that claim. Under 16 CFR 255.2, you need evidence for it, and if the experience is not typical, you must clearly disclose what people can generally expect. Disclose any discount or free session given in exchange for a review (16 CFR 255.5).
Credentials. Name your actual license, such as licensed massage therapist, physical therapist or osteopathic physician, and list method trainings as trainings. A certificate from a training course is not a state license; check with your board which titles you may use.
Packages. A package of sessions sold to “resolve” a condition implies a result. Sell the number of sessions, not the outcome. A “was $120, now $80” claim needs a real former price you actually charged for a reasonable time (16 CFR 233.1).
Combined offers. If you pair craniosacral with chiropractic, massage or cupping, keep each service’s claims separate and supported. Our guides to chiropractic marketing and cupping therapy marketing claims cover those services.

How we help

We build pages for massage, chiropractic, osteopathic and integrative practices with claims checked against the sources above: website design with service pages that describe the session honestly, healthcare SEO for searches like “craniosacral therapy near me,” and lead generation campaigns without cure or infant treatment claims. Osteopathic physicians should also read our guide to osteopathic practice marketing. We do not give legal or clinical opinions and we are not a law firm.

Can we say craniosacral therapy relieves back pain or headaches?

Only with care. A 2019 meta-analysis of 10 trials reported less chronic pain and disability, but a 2024 review of 15 trials found no meaningful change for headache, neck, low back or pelvic pain. If you mention pain, describe the evidence as mixed and avoid cure or guarantee wording.

Can we advertise craniosacral therapy for babies with colic?

We advise against colic or latch claims. The 2024 systematic review found craniosacral therapy was not effective for infant colic or preterm infants. You can describe a gentle session for parent and baby, and say it does not replace pediatric care.

Can we say we release restrictions in the craniosacral system?

That states a mechanism as fact. The 2024 review says the reliability of palpating the proposed craniosacral rhythm is not supported by sound evidence. Saying the method is based on that idea is accurate; saying you correct it is a claim you would need to prove.

Is craniosacral therapy safe to advertise as risk-free?

No. The 2024 review found most trials did not report adverse events, and those that did reported no serious ones. That is not enough to call a treatment risk-free. Ask about health conditions before the first session and say so on your site.

Can we post client reviews about craniosacral results?

Yes, but a review you feature is treated as your own claim under 16 CFR 255.2. If it describes a result you cannot support, or one that is not typical, edit your selection or add a clear statement of what clients can generally expect.

Does FDA regulate what we say about craniosacral sessions?

FDA’s device rules do not decide claims for a hands-on service. The FTC Act still applies to your ads, and your state board governs your license and scope. FDA’s general wellness guidance is a useful model for keeping copy on relaxation rather than disease.

Sources

More in Dental, vision, hearing and therapy marketing

Craniosacral therapy marketing: infant, pain and wellness claims